
#641Medicine & HealthFront Page15 March 2026
Why the Axial Spondyloarthritis Disease Activity Score May Set the Bar Too High
Clinical trials for axial spondyloarthritis often aim for total disease remission. A new meta-analysis suggests this strict target is rarely met, and low disease activity might be a more realistic measure of success.
By Abi Doumeth, Chaudhary, Gong, Petrinec, Matar, Mistry, Pamuk, Magrey